On Sept. 8, 2021, AIM ImmunoTech announced that is had submitted a Pre-Investigational New Drug application (Pre-IND) to…
On Sept. 8, 2021, Bio-Techne and Carterra announced a clinical research collaboration studying COVID-19 variants. To assess immune…
On Sept. 3, 2021, the Centers for Disease Control and Prevention (CDC) awarded more than $116 million in…
On Sept. 2 , 2021, an Oxford University Study showed that the most recent common ancestor of these…
On Sept. 2, 2021, Thermo Fisher Scientific announced a $192.5 million contract award from the U.S. Department of…
On Sept. 1, 2021, the World Health Organization inaugurated the new WHO Hub for Pandemic and Epidemic Intelligence…
On Sept. 1, 2021, Rigel Pharma announced the publication of results from a Phase 2 clinical trial evaluating…
On Sept. 1, 2021, Quidel announced it will make Quidelﾒs non-prescription QuickVueﾮ At-Home OTC COVID-19 Test available to…
On Aug. 31, 2021, RELIEF THERAPEUTICS reported that the parent company of its U.S. collaboration partner, NRx Pharmaceuticals…
On Aug. 31, 2021, Novartis announced a commercial agreement with the NHS in England as part of a…
On Aug. 31, 2021, SK bioscience and GlaxoSmithKline announced the initiation of a Phase 3 clinical study of…
On Aug. 30, 2021, CureVac announced the publication of its pivotal Phase 2b/3 (HERALD study) primary data of…
On Aug. 30, 2021, AXIMﾮ Biotechnologies announced that the Companyﾒs manufacturing partner Empowered Diagnostics had filed an amended…
On Aug. 30, 2021, OPKO announced completion of enrollment in its Phase 2 trial with RAYALDEEﾮ as a…
On Aug. 27, 2021, The National Institutes of Health announced that it had begun a clinical trial to…
On Aug. 27, 2021, the U.S. Department of Defense in coordination with the Department of Health and Human…
On Aug. 27, 2021, the USDA’s National Veterinary Services Laboratories announced confirmation of SARS-CoV-2 (the virus that causes…
On Aug. 26, 2021, the University of Nebraska Medical Center (UNMC) announced findings on airborne transmission have passed…
On Aug. 26, 2021, Pfizer and BioNTech announced the signing of a letter of intent with Eurofarma Laboratorios,…
On Aug. 25, 2021, the U.S. Department of Defense in coordination with the Department of Health and Human…
On Aug. 25, 2021, Johnson & Johnson announced data supporting the use of its COVID-19 vaccine as a…
On Aug. 23, 2021, Dynavax Technologies and Biological E announced the execution of a commercial supply agreement of…
On Aug. 22, 2021, InBios announced that laboratory studies suggest its SCoV-2 Ag Detect Rapid Test detected the…
On Aug. 20, 2021, Regeneron announced that the United Kingdom’s (UK) Medicines and Healthcare products Regulatory Agency had…
On Aug. 18, 2021, Agilent Technologies announced that researchers at the Indian Institute of Technology Bombay in India…
On Aug. 18, 2021, the final results of the Clinical Trial of COVID-19 Convalescent Plasma in Outpatients (C3PO)…
On Aug. 18, 2021, RELIEF THERAPEUTICS reported that the parent company of its U.S. collaboration partner, NRx Pharmaceuticals,…
On Aug. 17, 2021, Our Future Health published a new tender for the processing, genotyping, and storage of…
On Aug. 16, 2021, CureVac and GSK announced publication on the preprint server bioRxiv of preclinical data investigating…
On Aug. 16, 2021, scientists at the National Institutes of Health (NIH) announced they had developed a new…